vaccines

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough." 
 
 

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of $65,000 every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit —the equivalent of a ‘Big Pharma Davos’— from 16-18 November.

In response to the announcement that the World Health Organisation (WHO) has granted emergency use license for the COVID-19 vaccine, Covaxin, developed by Bharat Biotech in India, People’s Vaccine Alliance spokesperson and Oxfam Health Policy Manager, Anna Marriott, said: "Another approved vaccine to fight COVID-19 is fantastic news. We strongly encourage Bharat Biotech to show pandemic leadership and do the right thing for humanity by agreeing to share the vaccine technology and rights with the WHO's COVID Technology Access Pool, so that more manufacturers around the world can produce them.

In reaction to today’s global COVID summit hosted by President Biden, campaigners from the People’s Vaccine Alliance caution that ambitious goals to vaccinate the world will only be met with bold action to increase manufacturing, technology transfer, and access to COVID-19 vaccines around the world, not empty promises.

On the eve of President Biden’s global COVID-19 summit on the side-lines of the UN General Assembly, campaigners from the People’s Vaccine Alliance are calling for world leaders to go beyond empty promises of charity and deliver bold action to increase manufacturing and access to COVID-19 vaccines around the world.

More than 140 former heads of state and government and Nobel laureates today called on the candidates to be the next German chancellor Annalena Baerbock, Olaf Scholz, and Armin Laschet to declare themselves in favour of waiving intellectual property rules for COVID-19 vaccines and transferring vaccine technologies, and “to make these the policies of any future coalition government”. 

In response to the announcement today from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), which forecasts that 12 billion doses of COVID vaccines could be produced this year, Max Lawson, Chair of the People’s Vaccine Alliance and head of Inequality Policy at Oxfam, said: “While the world is finally producing billons of doses of COVID-19 vaccines there is no guarantee that developing nations will get them. Of the vaccines produced to date, only 0.5 per cent have gone to the poorest countries."
 

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 vaccines, campaigners from the People’s Vaccine Alliance said today.

In response to Jeff Bezos’ space flight scheduled for Tuesday, Deepak Xavier, Oxfam International's Global Head of Inequality Campaign, said: "We’ve now reached stratospheric inequality. Billionaires burning into space, away from a world of pandemic, climate change and starvation. 11 people are likely now dying of hunger each minute while Bezos prepares for an 11-minute personal space flight. This is human folly, not human achievement."

Responding to the news that the number of global deaths from COVID-19 has now passed 4 million, Anna Marriott, Oxfam’s health Policy Manager and spokesperson for the People’s Vaccine Alliance, said: “This is a horrific milestone and each one of these lives lost is a tragedy. Many of these deaths could have been prevented had the successful vaccine science been shared and production of doses ramped up by more manufacturers across the world."